We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CTTH market cap is 637.45k. The company's latest EPS is USD -0.0022 and P/E is -13.64.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 25k | 49k | 0 | 0 | 0 |
| Operating Income | -1.71M | -591k | -584k | -148k | -104k |
| Net Income | -1.73M | -586k | -586k | -133k | -46k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 781k | 573k | 376k | 108k | 8k |
| Total Liabilities | 281k | 450k | 663k | 103k | 5k |
| Total Equity | 500k | 123k | -287k | 5k | 3k |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -300k | -391k | -186k | -600k | -94k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 942k | N/A | N/A | 500k | N/A |
| Market Cap | 637.45k |
| Price to Earnings Ratio | -13.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 75 |
| Price to Book Ratio | 213.19 |
| Dividend Yield | - |
| Shares Outstanding | 21.32M |
| Average Volume (1 week) | 5.64k |
| Average Volume (1 Month) | 14.27k |
| 52 Week Change | 112.06% |
| 52 Week High | 0.10 |
| 52 Week Low | 0.003 |
| Spread (Intraday) | 0.02 (40%) |
| Company Name | CTT Pharmaceutical Holdings Inc (PK) |
| Address |
1100 – 1111 melville street vancouver, british columbia V6E 3V6 |
| Website | https://www.cttpharmaceuticals.com |
| Industry | gold and silver ores (1040) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
